PBS updates

Adcetris (Brentuximab vedotin)

brentuximab vedotin 50 mg injection, 1 vial · INJECTION · PBS code 11079D

AUTHORITY_REQUIRED

What it costs

AU$4422.25 PBS-determined price per pack

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2017-04-01.
  • • Repeats: 3.
  • • PBS program: IP.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Relapsed or Refractory Hodgkin lymphoma


Initial treatment


Patient must not have undergone an autologous stem cell transplant (ASCT) for this condition; AND

Patient must not be suitable for ASCT for this condition; or

Patient must not be suitable for treatment with multi-agent chemotherapy for this condition; AND

Patient must have experienced a relapsed CD30+ Hodgkin lymphoma following at least two prior treatments for this condition; or

Patient must have experienced a refractory CD30+ Hodgkin lymphoma following at least two prior treatments for this condition; AND

Patient must not receive more than 4 cycles of treatment under this restriction; AND

Patient must not have received prior treatment with this drug for this condition; or

Patient must not have failed PBS-subsidised treatment with this drug for this condition in the first-line setting.

Sponsor: Takeda Pharmaceuticals Australia Pty. Ltd. ABN 71 095 610 870

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.